Press Releases
SAN FRANCISCO, July 25, 2019 /PRNewswire/ -- PipelineRx, a leading medication management and telepharmacy company powered by clinical expertise and cloud technology, today announced the
Read more...25 July 2019
PLYMOUTH MEETING, Pa., July 25, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that positive results from the first-in-human trial of its vaccine against the Middle East Respiratory Syndrome Coronavirus (MERS) were published in
Read more...25 July 2019
EXTON, Pa., July 25, 2019 /PRNewswire/ -- Almirall, S.A. (ALM) announced today the opening of a new call for proposals for their
Read more...SEATTLE, July 25, 2019 /PRNewswire/ -- Viome, a company transforming health through personalized nutrition based on individual biology, today announces a collaboration with Mayo Clinic. The initial focus of the collaboration is two-fold: to better understand the role of nutrition in disease and to explore the potential of Viome's AI-driven personalized diets in helping
Read more...LAUREL, Md., July 25, 2019 /PRNewswire/ -- Maryland University of Integrative Health (MUIH) announced today that its M.S. Nutrition and Integrative Health program is now accredited by the Accreditation Council on Nutrition Professional Education (ACNPE; https://acnpe.org/accreditatio
Read more...STOCKTON, Calif., July 25, 2019 /PRNewswire/ -- TRC® Healthcare (Therapeutic Research Center or TRC), a leading provider of medication advisory and learning solutions and t
Read more...25 July 2019
More than 32,000 people traveled to Salt Lake for Young Living's 25 Years Young celebration LEHI, Utah, July 25, 2019 /PRNewswire/ --
Read more...SAN DIEGO, July 25, 2019 /PRNewswire/ -- April Hansen, Executive Vice President of Workforce Solutions and Clinical Services for Aya Healthcare, the company transforming
Read more...ATLANTA, July 25, 2019 /PRNewswire/ -- Oncology Analytics™, a data-driven utilization management company, which provides real-world, evidence-based analytics focused exclus
Read more...25 July 2019
SEOUL, South Korea, July 25, 2019 /PRNewswire/ -- LISCure Biosciences, a biotech company that researches and develops bacteria-mediated immunotherapy, has succeeded in attracting 5 million USD of seed funding investment. NHN Investment, Shinhan Investment, and KB Securities have participated in the financing, and LISCure is expected to stre
Read more...